Lipid profile test: what it checks, how to read it and UAE prices

What this test measures

  • Total CholesterolFrom the lab

    All the cholesterol carried in the blood, added together.

  • LDL CholesterolFrom the lab

    Cholesterol carried on the particles that deposit it in artery walls.

  • HDL CholesterolFrom the lab

    Cholesterol carried on the particles that return it to the liver.

  • TriglyceridesFrom the lab

    The main fat circulating in blood, and the form the body stores spare energy in.

  • Apolipoprotein B (ApoB)From the lab

    One of these proteins sits on every particle that can lodge in an artery wall, so this counts those particles directly.

  • Apolipoprotein A1 (ApoA1)From the lab

    The main protein on HDL particles, so it counts the particles that carry cholesterol away.

  • Lipoprotein(a) [Lp(a)]From the lab

    An LDL-like particle whose level is set largely by inherited genetics rather than by diet.

  • Non-HDL CholesterolDerived biomarker

    Total cholesterol less HDL, leaving every particle thought to drive plaque.

  • Total Cholesterol / HDL RatioDerived biomarker

    Total cholesterol divided by HDL, weighing all cholesterol against the fraction being cleared.

  • LDL / HDL RatioDerived biomarker

    LDL divided by HDL, setting the depositing particles against the clearing ones.

  • Triglycerides / HDL RatioDerived biomarker

    Triglycerides divided by HDL, a pairing that also tracks with insulin resistance.

  • ApoB / ApoA1 RatioDerived biomarker

    ApoB divided by ApoA1, counting the particles that deposit cholesterol against those that remove it.

  • Atherogenic Index of Plasma (AIP)Derived biomarker

    The base-ten logarithm of triglycerides divided by HDL, in matched molar units.

  • Remnant CholesterolDerived biomarker

    Total cholesterol less LDL and HDL, leaving what rides on triglyceride-rich remnant particles.

A lipid profile test is a blood test that measures the fats your blood carries: total cholesterol, LDL cholesterol, HDL cholesterol and triglycerides. Read together, they show how cholesterol is being moved around the body, and they are where a doctor starts when judging the risk of heart and blood vessel disease. Clare's panel takes the standard profile further, with apolipoproteins, lipoprotein(a) and a set of calculated ratios.

What a lipid profile measures

Cholesterol and triglycerides are carried in blood inside particles called lipoproteins, which take fat to tissues for energy, storage, hormone production and bile. The main types are chylomicrons, VLDL, IDL, LDL, lipoprotein(a) and HDL.

A standard profile measures total cholesterol, HDL cholesterol and triglycerides directly. LDL cholesterol is either measured directly or calculated from the other three, most often with the Friedewald formula: total cholesterol minus HDL minus triglycerides divided by 2.2, all in mmol/L (LDL = TC - HDL - TG/2.2). The formula cannot be used when triglycerides are above 4.5 mmol/L (400 mg/dL), so a report may show a directly measured LDL, or none, when triglycerides are high.

The four standard results

Total cholesterol is all the cholesterol in the sample, across every kind of lipoprotein, and it is one of the two lipid numbers most heart risk calculators use. HDL cholesterol is the other: the cholesterol on HDL particles, which carry cholesterol from the body back to the liver. LDL cholesterol is the cholesterol carried by LDL particles, the most numerous of the particles that can enter and stay in artery walls. European guidelines treat it as a cause of atherosclerosis, with risk tied to both the level and the years spent at it. Triglycerides are the main fat in blood, and their level reflects the triglyceride-rich particles, VLDL and its remnants, that carry them.

What Clare's panel adds

Clare's panel includes three more measurements from the lab. Apolipoprotein B (ApoB) counts the particles that can lodge in artery walls, because each of them carries a single ApoB molecule. Apolipoprotein A1 (ApoA1) is the main protein on HDL particles. Lipoprotein(a), or Lp(a), is an LDL-like particle; about 90% of a person's level is inherited, and the 2019 ESC/EAS guideline suggests measuring it at least once in each person's lifetime.

From these, Clare calculates seven results. Two are subtractions: non-HDL cholesterol is total cholesterol minus HDL, and remnant cholesterol is total cholesterol minus LDL minus HDL, the cholesterol riding on triglyceride-rich particles. Four are divisions: total cholesterol by HDL, LDL by HDL, triglycerides by HDL, and ApoB by ApoA1. The atherogenic index of plasma (AIP) is the base-ten logarithm of triglycerides divided by HDL, with both in mmol/L: AIP = log10(TG/HDL).

Who usually has a lipid profile

A lipid profile is the routine cholesterol test. MedlinePlus, the US National Library of Medicine's service, suggests adults have one every 5 years from age 20, every 1 to 2 years for men aged 45 to 65 and women aged 55 to 65, and every year after 65, with more frequent testing for people with a family history of heart disease, high blood pressure, diabetes, smoking or obesity.

Doctors also order it to estimate overall cardiovascular risk and to see whether a change in diet, weight or treatment has moved the numbers.

How to prepare

For most people, fasting is not needed for cholesterol. A joint consensus of the European Atherosclerosis Society and the European Federation of Clinical Chemistry and Laboratory Medicine recommends non-fasting samples as the routine, and NICE in the UK does not require a fasting sample. After an ordinary meal the average changes are small: triglycerides about 0.3 mmol/L higher, total and LDL cholesterol about 0.2 mmol/L lower, and HDL, ApoA1, ApoB and Lp(a) unchanged.

Fasting still has a place. The same consensus suggests a fasting sample when non-fasting triglycerides are above 5 mmol/L (440 mg/dL), and when other tests in the same draw need one, such as fasting glucose. Clare's panel includes fasting glucose and fasting insulin, so its lipids come from that same fasting sample. Follow the fasting instructions you are given, and mention any medicines, a recent illness, a pregnancy or a recent birth to the person taking the sample, since each can move the numbers.

Reading the results together

Total cholesterol, LDL, HDL and triglycerides each have their own page with their ranges. What the profile adds is the pattern, and a few patterns come up often.

Raised LDL with normal triglycerides

This points to cholesterol carried mainly on LDL particles. A doctor usually weighs it against overall risk: age, blood pressure, smoking, diabetes and family history. A markedly high LDL raises the question of an inherited cause, familial hypercholesterolaemia, so the doctor will usually ask about relatives with high cholesterol or early heart disease.

High triglycerides with low HDL

This pairing often travels with insulin resistance, weight carried around the waist and type 2 diabetes. In this pattern LDL cholesterol can understate the number of particles that matter, so the 2019 ESC/EAS guideline recommends reading ApoB and non-HDL cholesterol alongside it. Remnant cholesterol, the triglycerides / HDL ratio and AIP describe the same picture from different angles.

LDL and ApoB that disagree

For most people, LDL, non-HDL cholesterol and ApoB tell the same story. The guideline notes that in around 20% of patients measured LDL and ApoB can disagree, and it treats ApoB as the more accurate count of the particles that drive risk. The post ApoB: the cholesterol number most UAE panels skip walks through that pattern.

Lp(a) on its own terms

Because Lp(a) is largely inherited, it is read apart from the rest. A high level can mark a higher risk that the usual lipids and risk scores do not show, and it can move a person's estimated risk from one category to another.

What a doctor typically checks next

When a profile is out of range, the usual next steps are a repeat test and a look for common secondary causes: excess alcohol, uncontrolled diabetes, an underactive thyroid, liver disease and nephrotic syndrome, a kidney condition that leaks protein. Before any treatment, NICE lists baseline checks that include diabetes status, kidney function, liver enzymes, and TSH where there are thyroid symptoms. Very high triglycerides are handled differently, with a repeat on a fasting sample and specialist advice, because of the risk of pancreatitis.

Ranges for the calculated results

Five of the calculated results in Clare's panel do not have a page of their own yet. None of them has a single guideline range, so treat the figures below as reference points from the research behind them, not cut-offs a lab would flag.

ResultFigure in useWhere it comes from
Remnant cholesterolFlagged at 0.8 mmol/L (30 mg/dL) or above on a fasting sample, 0.9 mmol/L (35 mg/dL) or above non-fastingEAS and EFLM joint consensus, 2016
LDL / HDL ratioAbove 3.5 in men or 3.0 in women read as higher risk; below 3.0 in men or 2.5 in women given as prevention targetsReview of lipoprotein ratios, 2009
ApoB / ApoA1 ratioAbove 1.0 in men or 0.9 in women read as higher risk; below 0.9 in men or 0.8 in women given as prevention targetsReview of lipoprotein ratios, 2009
Triglycerides / HDL ratioNo agreed range. One study of overweight adults used 3.0, with both values in mg/dL, to pick out likely insulin resistance; the same ratio is a smaller number in mmol/LStudy of 258 adults, 2003
Atherogenic index of plasmaStudies often group it as below 0.11, 0.11 to 0.21, and above 0.21, with both values in mmol/LResearch use, for example a 2018 study

Lipids in the UAE

The clearest local figures come from the UAE National Diabetes and Lifestyle Study. Among 824 Emirati adults in the Northern Emirates, tested on fasting samples in 2012 and 2013, 72.5% had at least one lipid result outside the study's cut-offs: 42.8% had high total cholesterol, 38.6% high LDL, 29% high triglycerides and 42.5% low HDL. Weight carried around the waist and diabetes were linked with high triglycerides and low HDL. The study covered Emirati nationals, not the expatriate majority, so it describes one part of the country.

A registry of outpatient records at 14 hospitals in five Gulf countries, the UAE among them, estimated familial hypercholesterolaemia at about 1 in 112, roughly three times the estimate worldwide. The authors describe it as a snapshot that needs confirming in population studies.

Ramadan shifts meal times for a month. A 2019 meta-analysis of 33 studies in healthy people found the average lipid changes across Ramadan were small, within about 3 mg/dL each, though the timing is worth noting when two tests are compared.

Price

When we read public prices on 11 October 2026, a lipid profile cost from 89 to 199 at six UAE providers. VAT was rarely stated. Some prices included a nurse's home visit, while one provider added a collection fee on smaller orders. Extended lipid packages cost more: one that added ApoB and Lp(a) was listed at 1,100.

Related tests

Lipids are usually read beside blood sugar. The HbA1c and diabetes test, with Hemoglobin A1c, fasting glucose and fasting insulin, shows whether insulin resistance sits behind high triglycerides and low HDL; the post on reading HbA1c, glucose and insulin together explains how. The thyroid test, led by Thyroid-Stimulating Hormone (TSH), and the liver function test cover two of the common secondary causes of high cholesterol.

Why the numbers mean more over time

Lipids move from one test to the next even when nothing has changed. One review estimated that behaviour, health and the way a sample is taken account for about 60% of the total variation in a person's reported lipid result. A single profile is a snapshot; two or three show a direction. NICE recommends repeating the full profile 2 to 3 months after starting or changing lipid-lowering treatment, and a yearly profile to guide ongoing prevention. When Clare opens, each new result will sit beside your earlier ones, so a change reads as a change rather than as a new number. Clare is opening with a waitlist at clare.health.

See all 100+ markers in the Clare panel

  1. ESC/EAS, 2019 Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) https://doi.org/10.1016/j.atherosclerosis.2019.08.014
  2. European Atherosclerosis Society and EFLM, Fasting is not routinely required for determination of a lipid profile, joint consensus statement (2016) https://pmc.ncbi.nlm.nih.gov/articles/PMC4929379/
  3. NICE, Cardiovascular disease: risk assessment and reduction, including lipid modification, NG238 (2023) https://www.nice.org.uk/guidance/ng238/chapter/Recommendations
  4. NHS, Cholesterol levels (2026) https://www.nhs.uk/conditions/high-cholesterol/cholesterol-levels/
  5. MedlinePlus, Cholesterol levels: what you need to know (2024) https://medlineplus.gov/lab-tests/cholesterol-levels/
  6. MedlinePlus, HDL: the good cholesterol (2026) https://medlineplus.gov/hdlthegoodcholesterol.html
  7. Millán et al., Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention, Vascular Health and Risk Management (2009) https://pmc.ncbi.nlm.nih.gov/articles/PMC2747394/
  8. Wang et al., Atherogenic index of plasma is a novel predictor of non-alcoholic fatty liver disease in obese participants, Lipids in Health and Disease (2018) https://pmc.ncbi.nlm.nih.gov/articles/PMC6293612/
  9. McLaughlin et al., Use of metabolic markers to identify overweight individuals who are insulin resistant, Annals of Internal Medicine (2003) https://pubmed.ncbi.nlm.nih.gov/14623617/
  10. Mahmoud and Sulaiman, Dyslipidaemia prevalence and associated risk factors in the United Arab Emirates: a population-based study, BMJ Open (2019) https://pmc.ncbi.nlm.nih.gov/articles/PMC6858122/
  11. Alhabib et al., Familial hypercholesterolemia in the Arabian Gulf region: clinical results of the Gulf FH Registry, PLOS ONE (2021) https://pmc.ncbi.nlm.nih.gov/articles/PMC8177652/
  12. Mirmiran et al., Effects of Ramadan intermittent fasting on lipid and lipoprotein parameters: an updated meta-analysis, Nutrition, Metabolism and Cardiovascular Diseases (2019) https://pubmed.ncbi.nlm.nih.gov/31377182/
  13. Cooper et al., Blood lipid measurements: variations and practical utility, JAMA (1992) https://pubmed.ncbi.nlm.nih.gov/1542176/
  14. Intel Lab, Lipid Profile, price read 11 October 2026 https://intel-lab.ae/biomarkers/lipid-profile
  15. Dr Plus, Lipid Profile, price read 11 October 2026 https://drplus.ae/blood-test-at-home-dubai/
  16. NMC Healthcare, Lipid Profile (Specialised Health Package), price read 11 October 2026 https://nmc.ae/en/health-packages/specialised-health-packages

Last updated